• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Elicera Therapeutics' new issue heavily oversubscribed firstwordpharma
    June 10, 2021
    ​Elicera Therapeutics announced today that the Company's issue of units of approximately SEK 52 million prior to the planned listing on the Nasdaq First North Growth Market was subscribed for approximately 171 percent spread over about 3 600 subscribers.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service